Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic-Myeloproliferative Diseases 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 20fludarabine phosphate 17Whole-Body Irradiation 15fludarabine 14Melphalan 14Tacrolimus 13Busulfan 12Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Cyclosporine 6Antilymphocyte Serum 6Alemtuzumab 6Methotrexate 5Stem Cell Transplantation 4thymoglobulin 3Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2visilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Aplastic × posaconazole × Myeloid × Clear all
NCT02875743 2020-04-02

King's Invasive Aspergillosis Study II

King's College Hospital NHS Trust

Phase 4 Completed
120 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡